ENDRA Life Sciences (Nasdaq: NDRA) logo

ENDRA Life Sciences (Nasdaq: NDRA)

Focused on early detection of liver disease

25 employees · est. 2009 · Ann Arbor, United States

VS
Sonic Incytes Medical Corp. logo

Sonic Incytes Medical Corp.

Creators of VELACUR: point-of-care AI guided ultrasound elastography for chronic liver diseases such as MASLD and MASH

41 employees · est. 2017 · Canada

ENDRA Life Sciences (Nasdaq: NDRA) is the older company (2009 vs 2017).

Side-by-Side Comparison

ENDRA Life Sciences (Nasdaq: NDRA) Sonic Incytes Medical Corp.
Founded
2009 older 2017
Headquarters
Ann Arbor, United States Canada
Employees
25 41
Industry
Biotechnology, Health Care, Medical Devices Health Care, Medical Devices
Funding Stage
Post Ipo Equity Series A
Total Funding
$8.99M $11.80M
Funding Rounds
2 5
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Enhanced Ultrasound Technologies, TAEUS Platform, Liver Disease Detection, Non-Alcoholic Fatty Liver Disease (NAFLD), Medical Imaging Technology, Point-of-care Diagnostics, Liver Health Monitoring, Non-invasive Diagnostics, Healthcare Cost Reduction, Early Disease Detection, Medical Device Innovation, Liver Fat Quantification, Medical Technology Startups, Healthcare Accessibility Point-of-Care Diagnostics, AI Guided Imaging, Ultrasound Elastography, Chronic Liver Diseases, Diagnostic Solutions, Quantitative Ultrasound, Procedure Guidance, Medical Imaging, Fatty Liver Disease, Diagnostic Accuracy
Website
endrainc.com sonicincytes.com
ENDRA Life Sciences (Nasdaq: NDRA) logo

About ENDRA Life Sciences (Nasdaq: NDRA)

ENDRA Life Sciences Inc. (NDRA) is a biotechnology company headquartered in the United States and founded in 2007. The company's focus is on early detection of liver disease, particularly Non-Alcoholic Fatty Liver Disease (NAFLD), which affects over 1 billion people globally and is estimated to cost...

Sonic Incytes Medical Corp. logo

About Sonic Incytes Medical Corp.

Sonic Incytes Medical Corp. is a Canadian-based startup committed to revolutionizing patient care through innovative diagnostic solutions. Their flagship product, VELACUR, is a point-of-care AI-guided ultrasound elastography designed to aid in the management of chronic liver diseases such as MASLD a...

Be first to know when either one moves

Funding rounds, hiring surges, leadership changes and stack switches at ENDRA Life Sciences (Nasdaq: NDRA) and Sonic Incytes Medical Corp. — tracked continuously, sent the day they land.

Watch both — free

Funding, hiring, leadership and stack changes at ENDRA Life Sciences (N... and Sonic Incytes Medical... — by email.

Frequently Asked Questions

ENDRA Life Sciences (Nasdaq: NDRA) — Focused on early detection of liver disease. Sonic Incytes Medical Corp. — Creators of VELACUR: point-of-care AI guided ultrasound elastography for chronic liver diseases such as MASLD and MASH. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
ENDRA Life Sciences (Nasdaq: NDRA) has raised $8.99M while Sonic Incytes Medical Corp. has raised $11.80M.
ENDRA Life Sciences (Nasdaq: NDRA) and Sonic Incytes Medical Corp. operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare ENDRA Life Sciences (Nasdaq: NDRA) with someone else

Start typing a company name or domain.

One analytics cookie (Google Analytics). Cookie Policy